World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon

Biotech companies at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

49 biotech companies are at World Vaccine Congress Europe 2026 — 56 presentations on the program and 33 with a booth in the exhibit hall. Most represented: Tonix Pharmaceuticals (3 on the program), DIOSynVax (2 on the program), Abera Bioscience (2 on the program). 39 of them have their own page in this guide. As of Oct 12, 2026.

All 268 organizations at World Vaccine Congress Europe 2026 →

Topic
Top represented
Showing 1–13 of 49 organizations
OrganizationWorld Vaccine Congress Europe 2026 Attendance
BiotechSilver sponsor
Biopharmaceutical company whose vaccine work includes TNX-801, a horsepox-based vaccine platform.
Booth
Exhibiting (no floor booth listed)
Talk
Tue Oct 20
11:30
Working Group: Vectored Vaccine Platforms: from design to improving efficacy
Working Groups · with Kenya Medical Research Institute
Platforms & delivery
Talk
Wed Oct 21
13:15
TNX-801 vaccine platform safety and efficacy
Emerging & Infectious Diseases
DIOSynVax
Cambridge, United Kingdom
Biotech
Uses computational antigen design to develop broadly protective vaccines against influenza, coronaviruses and other viral threats.
Talk
Mon Oct 19
11:15
AI designed universal vaccine technology to prevent future virus outbreaks
Workshop: Platform Technologies
Session
Tue Oct 20
14:00
Track Chair
Technology Showcases
Session
Tue Oct 20
16:00
Track Chair
Technology Showcases
Talk
Wed Oct 21
13:45
Next Generation vaccines to prevent cross-species transmission of Influenza
One Health & Veterinary
BiotechShowcase sponsor
Develops mucosal vaccines against serious infectious diseases on a proprietary platform of outer membrane vesicles (OMVs).
Booth
Exhibiting (no floor booth listed)
Talk
Mon Oct 19
10:30
Novel OMV platform for mucosal vaccines
Workshop: Platform Technologies
Talk
Wed Oct 21
10:30
From Innovation to Impact: Translating OMV Vaccine Technology into Clinical Reality
How a developer and a contract manufacturer take vaccines made from outer membrane vesicles, tiny bacterial bubbles, from research toward clinical trials.
with NorthX Biologics
BiotechBronze sponsor
Uses its AI-Immunology platform to discover and design vaccines against bacterial and viral infections and cancer.
Booth
Exhibiting at Booth 216
Talk
Wed Oct 21
11:00
AI-Immunology™-Powered Development of Vaccines Against Bacterial Infections
AMR & Bacterial Vaccines
Talk
Wed Oct 21
11:30
AI-Immunology for the discovery and design of novel vaccine targets
Emerging & Infectious Diseases
Session
Wed Oct 21
10:30
Track Chair
AMR & Bacterial Vaccines
Session
Wed Oct 21
12:15
Track Chair
AMR & Bacterial Vaccines
Inimmune
Missoula, MT
Biotech
Biotech designing and developing TLR agonist adjuvants and immunotherapeutics.
Talk
Mon Oct 19
14:00
Workshop Leader’s Opening Remarks
Workshop: Vaccine Delivery
Talk
Wed Oct 21
10:45
Innovative Adjuvants for Global Health
Bioprocess & Manufacturing · with SPI Pharma
Biotech
Develops vaccines against zoonotic and animal diseases using herpesvirus vectors.
Session
Wed Oct 21
10:30
Chair’s opening remarks
One Health & Veterinary
Session
Wed Oct 21
13:15
Track Chair
One Health & Veterinary
BiotechStart-up Plus
Develops bacteriophage treatments, viruses that kill bacteria, as an answer to antibiotic resistance, starting with cholera.
Booth
Exhibiting at Booth SU4
Talk
Tue Oct 20
12:50
Start-up Pitch 3: PhagePro
Startup Pitches
Infectious disease & AMR
Vaxxirna
Houston, TX
BiotechShowcase sponsor
Develops circular RNA vaccines for infectious diseases, with heat-stable lipid nanoparticle formulations and microneedle patch delivery.
Booth
Exhibiting (no floor booth listed)
Talk
Tue Oct 20
16:00
Safe and Efficacious Circular RNA Vaccines to Treat Yellow Fever and Dengue
Technology Showcases
Infectious disease & AMRPlatforms & delivery
SB
Sagitta Biotech
Biotech
Develops targeted viral vectors that deliver toxic payloads to solid tumors, with efficacy data in glioblastoma.
Talk
Wed Oct 21
10:40
HL
Hilleman Laboratories
Singapore, Singapore
BiotechShowcase sponsor
Vaccine research and development organization, founded by MSD and Wellcome, developing affordable vaccines for low- and middle-income countries.
Booth
Exhibiting (no floor booth listed)
Talk
Tue Oct 20
11:30
Working Group: Partnerships for Prevention: Accelerating Vaccines to Curb Antimicrobial Resistance
How partnerships across sectors could speed up and widen access to vaccines against drug-resistant bacteria, such as a maternal Klebsiella vaccine for newborns.
with CARB-X, World Health Organization (WHO), University of Maryland School of Medicine +1 more
Infectious disease & AMRSupply, safety & access
Talk
Wed Oct 21
09:00
The New Geopolitics of Vaccines: Global Vaccine Manufacturing in a Fractured World
How governments and industry can keep vaccines flowing fairly across borders in an emergency as countries push to make vaccines at home.
with European Commission, Access to Medicine Foundation, UNICEF +1 more
Supply, safety & accessBioprocess & manufacturing
Talk
Wed Oct 21
12:15
Panel: The New Geography of Vaccine Innovation: Why the Next Decade of Vaccine Development Will Be Driven by LMICs
Why low- and middle-income countries are becoming vaccine innovators, not just trial sites, and what funding and regional regulatory cooperation they need.
with International Vaccine Institute, Luipaard, Health Emergency Preparedness and Response Authority
Session
Wed Oct 21
10:30
Track Chair
Respiratory
Talk
Wed Oct 21
10:30
Universal influenza vaccine: Results from phase 1 clinical trial
Respiratory
Session
Wed Oct 21
13:45
Track Chair
Respiratory
Biotech
Spanish vaccine company in the Zendal group developing and manufacturing the MTBVAC tuberculosis vaccine.
Talk
Wed Oct 21
12:45
Global Manufacturing and Access Strategy for a TB Vaccine: MTBVAC
AMR & Bacterial Vaccines
Panel
Wed Oct 21
14:30
Panel: Can TB vaccines deliver on the promise?
What tuberculosis vaccine trials can learn from COVID-19, flu and respiratory syncytial virus, and how to make tuberculosis a funding priority.
with London School of Hygiene & Tropical Medicine, Novo Nordisk Foundation Initiative for Vaccines and Immunity, GSK +2 more

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from biotech companies

Tell us what you sell and we’ll find the people at these biotech companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse World Vaccine Congress Europe 2026 by

Exhibit hall

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction